We are live on
!
Find out more
BLRX
BioLineRX
BLRX
BLRX
9 hedge funds and large institutions have $3.91M invested in BioLineRX in 2013 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $2.58M | +$2.74M | +2,649 | New |
|
|
SM
2
Senvest Management
New York
| $1.01M | +$1.08M | +1,041 | New |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $200K | +$214K | +207 | New |
|
4
Renaissance Technologies
New York
| $48K | +$51.8K | +50 | New |
|
5
Bank of New York Mellon
New York
| $29K | +$31.1K | +30 | New |
|
|
CS
6
Credit Suisse
Zurich,
Switzerland
| $25K | +$26.9K | +26 | New |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $19K | +$20.7K | +20 | New |
|
8
Wells Fargo
San Francisco,
California
| $2K | +$2.07K | +2 | New |
|
9
Citigroup
New York
| $1K | +$1.04K | +1 | New |
|
BLRX Hedge Fund Activity: Q2 2013 in Review
9 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in BioLineRX (BLRX) for Q2 2013, worth a combined $3.91M.
Buyers outnumbered sellers: 9 funds opened new BLRX positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
- 9 institutional investors held BioLineRX (BLRX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $3.91M of BioLineRX stock for Q2 2013.
- 9 funds opened new BioLineRX positions in Q2 2013 and 0 closed out, a net change of +9 holders.
Based on aggregated 13F filings for Q2 2013.